Drug May Boost Women's Sexual Desire
Study Shows Flibanserin Increases Satisfying Encounters for Women With Low Libido
(continued)
Second Opinion continued...
Boehringer Ingelheim is continuing studies. Recruitment of both premenopausal and postmenopausal women with HSDD for new clinical trials is beginning, Sand says.
He wouldn't comment on a possible timeline of when the drugmaker might ask for FDA approval or when it may be on the market.
© 2009 WebMD, LLC. All rights reserved.


